201 related articles for article (PubMed ID: 11297254)
1. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
Matsumura T; Makino R; Mitamura K
Clin Cancer Res; 2001 Mar; 7(3):594-9. PubMed ID: 11297254
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
4. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
7. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
[TBL] [Abstract][Full Text] [Related]
9. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
11. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
Chang HW; Chow V; Lam KY; Wei WI; Yuen A
Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
[TBL] [Abstract][Full Text] [Related]
13. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
17. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
[TBL] [Abstract][Full Text] [Related]
18. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
19. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
20. Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.
Yamada S; Nomoto S; Fujii T; Takeda S; Kanazumi N; Sugimoto H; Nakao A
Anticancer Res; 2007; 27(4B):2269-74. PubMed ID: 17695513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
